Mahasirimongkol, S.; Khunphon, A.; Kwangsukstid, O.; Sapsutthipas, S.; Wichaidit, M.; Rojanawiwat, A.; Wichuckchinda, N.; Puangtubtim, W.; Pimpapai, W.; Soonthorncharttrawat, S.;
et al. The Pilot Study of Immunogenicity and Adverse Events of a COVID-19 Vaccine Regimen: Priming with Inactivated Whole SARS-CoV-2 Vaccine (CoronaVac) and Boosting with the Adenoviral Vector (ChAdOx1 nCoV-19) Vaccine. Vaccines 2022, 10, 536.
https://doi.org/10.3390/vaccines10040536
AMA Style
Mahasirimongkol S, Khunphon A, Kwangsukstid O, Sapsutthipas S, Wichaidit M, Rojanawiwat A, Wichuckchinda N, Puangtubtim W, Pimpapai W, Soonthorncharttrawat S,
et al. The Pilot Study of Immunogenicity and Adverse Events of a COVID-19 Vaccine Regimen: Priming with Inactivated Whole SARS-CoV-2 Vaccine (CoronaVac) and Boosting with the Adenoviral Vector (ChAdOx1 nCoV-19) Vaccine. Vaccines. 2022; 10(4):536.
https://doi.org/10.3390/vaccines10040536
Chicago/Turabian Style
Mahasirimongkol, Surakameth, Athiwat Khunphon, Oraya Kwangsukstid, Sompong Sapsutthipas, Mingkwan Wichaidit, Archawin Rojanawiwat, Nuanjun Wichuckchinda, Wiroj Puangtubtim, Warangluk Pimpapai, Sakulrat Soonthorncharttrawat,
and et al. 2022. "The Pilot Study of Immunogenicity and Adverse Events of a COVID-19 Vaccine Regimen: Priming with Inactivated Whole SARS-CoV-2 Vaccine (CoronaVac) and Boosting with the Adenoviral Vector (ChAdOx1 nCoV-19) Vaccine" Vaccines 10, no. 4: 536.
https://doi.org/10.3390/vaccines10040536
APA Style
Mahasirimongkol, S., Khunphon, A., Kwangsukstid, O., Sapsutthipas, S., Wichaidit, M., Rojanawiwat, A., Wichuckchinda, N., Puangtubtim, W., Pimpapai, W., Soonthorncharttrawat, S., Wanitchang, A., Jongkaewwattana, A., Srisutthisamphan, K., Phainupong, D., Thawong, N., Piboonsiri, P., Sawaengdee, W., Somsaard, T., Ritthitham, K.,
... Phumiamorn, S.
(2022). The Pilot Study of Immunogenicity and Adverse Events of a COVID-19 Vaccine Regimen: Priming with Inactivated Whole SARS-CoV-2 Vaccine (CoronaVac) and Boosting with the Adenoviral Vector (ChAdOx1 nCoV-19) Vaccine. Vaccines, 10(4), 536.
https://doi.org/10.3390/vaccines10040536
